We are live on ! Find out more
Davidson & Garrard

Davidson & Garrard Portfolio holdings

AUM $425M Turnover 4.35%
1-Year Est. Return 14.62%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+14.62%
3 Year Est. Return
+25.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$406M
AUM Growth
+$15.2M
Cap. Flow
+$2.28M
Cap. Flow %
0.56%
Top 10 Hldgs %
23.4%
Holding
193
New
10
Increased
61
Reduced
82
Closed
4
Avg Time Held
2.4 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
2 years

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$1.5M
2
V icon
Visa
V
+$990K
3
NCMI icon
National CineMedia
NCMI
+$958K
4
NKE icon
Nike
NKE
+$817K
5
CELG
Celgene Corp
CELG
+$805K

Top Sells

Rank Stock Value
1
DNY
DONNELLEY R R & SONS CO
DNY
+$1.11M
2
CHKP icon
Check Point Software Technologies
CHKP
+$448K
3
MCD icon
McDonald's
MCD
+$440K
4
ORCL icon
Oracle
ORCL
+$437K
5
IBM icon
IBM
IBM
+$410K

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.69%
2 Healthcare 17.17%
3 Technology 12.5%
4 Financials 10.09%
5 Communication Services 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.02T
$12.7M 3.12%
530,644
+9,248
+2% +$230K
2013 Q2
12 quarters
VZ icon
2
Verizon
VZ
$181B
$10.3M 2.54%
184,600
+962
+0.5% +$49.9K
2013 Q2
12 quarters
GE icon
3
GE Aerospace
GE
$307B
$10.3M 2.53%
68,004
-788
-1% -$115K
2013 Q2
12 quarters
PFF icon
4
iShares Preferred and Income Securities ETF
PFF
$11.9B
$10M 2.46%
250,525
+1,162
+0.5% +$45.5K
2013 Q2
12 quarters
CVS icon
5
CVS Health
CVS
$120B
$9.5M 2.34%
99,305
-286
-0.3% -$28.5K
2013 Q2
12 quarters
T icon
6
AT&T
T
$150B
$9.16M 2.26%
280,680
+3,702
+1% +$110K
2013 Q2
12 quarters
TMO icon
7
Thermo Fisher Scientific
TMO
$257B
$9.06M 2.23%
61,347
-1,180
-2% -$174K
2013 Q2
12 quarters
XOM icon
8
ExxonMobil
XOM
$732B
$8.92M 2.2%
95,101
+69
+0.1% +$6.1K
2013 Q2
12 quarters
BDX icon
9
Becton Dickinson
BDX
$52.9B
$7.8M 1.92%
47,172
-1,908
-4% -$305K
2013 Q2
12 quarters
PEP icon
10
PepsiCo
PEP
$184B
$7.31M 1.8%
69,030
-1,206
-2% -$124K
2013 Q2
12 quarters
ABBV icon
11
AbbVie
ABBV
$503B
$6.95M 1.71%
112,314
-138
-0.1% -$8.41K
2013 Q2
12 quarters
JPM icon
12
JPMorgan Chase
JPM
$890B
$6.52M 1.61%
104,897
+1,804
+2% +$113K
2013 Q2
12 quarters
PG icon
13
Procter & Gamble
PG
$364B
$6.34M 1.56%
74,817
-532
-0.7% -$43.7K
2013 Q2
12 quarters
SE icon
14
DELISTED
Spectra Energy Corp Wi
SE
$6.27M 1.54%
171,080
+1,697
+1% +$54.1K
2013 Q2
12 quarters
MSFT icon
15
Microsoft
MSFT
$3.96T
$6.11M 1.5%
119,336
+480
+0.4% +$24.9K
2013 Q2
12 quarters
JNJ icon
16
Johnson & Johnson
JNJ
$621B
$6.04M 1.49%
49,785
-159
-0.3% -$18.1K
2013 Q2
12 quarters
MCK icon
17
McKesson
MCK
$118B
$5.99M 1.48%
32,111
+82
+0.3% +$14.4K
2013 Q2
12 quarters
PFE icon
18
Pfizer
PFE
$170B
$5.74M 1.41%
171,829
+5,119
+3% +$163K
2013 Q2
12 quarters
MCHP icon
19
Microchip Technology
MCHP
$41.9B
$5.54M 1.37%
218,422
-4,690
-2% -$117K
2013 Q2
12 quarters
INTC icon
20
Intel
INTC
$491B
$5.54M 1.36%
168,914
-625
-0.4% -$19.6K
2013 Q2
12 quarters
IVV icon
21
iShares Core S&P 500 ETF
IVV
$892B
$5.35M 1.32%
25,415
+2,636
+12% +$550K
2013 Q2
12 quarters
NNN icon
22
NNN REIT
NNN
$7.82B
$5.34M 1.31%
103,167
-2,355
-2% -$109K
2013 Q2
12 quarters
MRK icon
23
Merck
MRK
$370B
$5.31M 1.31%
96,548
+288
+0.3% +$15.3K
2013 Q2
12 quarters
ESRX
24
DELISTED
Express Scripts Holding Company
ESRX
$5.25M 1.29%
69,251
-658
-0.9% -$48.4K
2013 Q2
12 quarters
IJH icon
25
iShares Core S&P Mid-Cap ETF
IJH
$123B
$5.14M 1.27%
171,885
-5,160
-3% -$151K
2013 Q2
12 quarters
1
2 3 4 5

Similar funds

SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return
Jacobus Wealth Management
Jacobus Wealth Management Milwaukee, Wisconsin $382M AUM 16.31% 1-Year Est. Return
North Tide Capital
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
MCL
MIK Capital LLC New York $344M AUM 26.72% 1-Year Est. Return
Neuberger Berman Canada
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
GIIO
Gen IV Investment Opportunities New York $269M AUM 21.06% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
FIC Capital
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

Davidson & Garrard's Q2 2016 Portfolio in Review

As of Q2 2016, Davidson & Garrard held 193 positions worth $406M, up 3.9% from $391M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Davidson & Garrard's Q2 2016 filing shows 10 new, 61 increased, 82 reduced and 4 closed positions. Its largest new stake was Visa: 12,638 shares worth $937K. The largest sale was DONNELLEY R R & SONS CO, an estimated $1.11M.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Davidson & Garrard's largest Q2 2016 buy was Visa: 12,638 shares worth $937K.
  • Davidson & Garrard added most to Starbucks in Q2 2016, an estimated $1.5M increase.
  • Davidson & Garrard's biggest Q2 2016 reduction was DONNELLEY R R & SONS CO, cutting an estimated $1.11M.
  • Davidson & Garrard fully exited Allergan plc in Q2 2016, selling an estimated $224K.
  • Davidson & Garrard's ten largest holdings make up 23% of its $406M portfolio in Q2 2016.
  • Davidson & Garrard opened 10 new positions and closed 4 in Q2 2016.
  • Davidson & Garrard's portfolio value rose 3.9% quarter-over-quarter to $406M.

Based on Davidson & Garrard's 13F filing for Q2 2016, filed 4 Aug 2016.